#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16390	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2064	781.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	967	C	926	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16390	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2064	781.2	0	HET	.	.	.	C451T	.	451	451	C	674	674	C	918	C,T	636,242	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16390	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2064	781.2	0	HET	.	.	.	C207T,G	.	207	207	C	430	430	C	913	C,T,G	693,171,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30240	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3460	863.9	0	.	n	.	0	T695C	SNP	695	695	T	985	985	C	846	C	810	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30240	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3460	863.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2261	2261	C	909	C,T	863,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30240	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3460	863.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2335	2335	A	923	A,G	891,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30240	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3460	863.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2887	2887	C	922	C	885	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1936	folP	855	855	100.0	folP.l15.c4.ctg.1	1429	133.1	1	SNP	p	R229S	1	.	.	685	687	AGC	968	970	AGC	219;219;219	A;G;C	208;209;206	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5814	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3344	171.6	1	SNP	p	S91F	1	.	.	271	273	TTC	535	537	TTC	196;196;200	T;T;C,T	190;191;192,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5814	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3344	171.6	1	SNP	p	G95N	0	.	.	283	285	GGC	547	549	GGC	196;196;195	G;G;C	187;185;187	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5814	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3344	171.6	1	SNP	p	D95G	1	.	.	283	285	GGC	547	549	GGC	196;196;195	G;G;C	187;185;187	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1728	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1300	131.3	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	218;215;213	G,C;G,A;C	210,1;207,1;202	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	860	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	905	93.5	0	.	n	.	0	A197.	DEL	197	197	A	487	487	A	202	A	196	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3056	190.1	1	SNP	p	D86N	0	.	.	256	258	GAC	594	596	GAC	249;249;251	G;A;C	238;231;240	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3056	190.1	1	SNP	p	S87R	1	.	.	259	261	CGT	597	599	CGT	251;252;253	C,A;G;T	241,1;240;237	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3056	190.1	1	SNP	p	R87I	0	.	.	259	261	CGT	597	599	CGT	251;252;253	C,A;G;T	241,1;240;237	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3056	190.1	1	SNP	p	R87W	0	.	.	259	261	CGT	597	599	CGT	251;252;253	C,A;G;T	241,1;240;237	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3056	190.1	1	SNP	p	S88P	0	.	.	262	264	TCC	600	602	TCC	252;253;256	T;C;C	236;242;245	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4430	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2641	165.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1554	1556	GGC	213;212;212	G;G;C	204;203;198	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1252	1254	GCC	241;243;246	G;C;C	224;231;234	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1255	1257	ATG	246;246;243	A;T;G,T	236;232;227,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1267	1269	ACC	238;240;241	A,C;C;C	223,1;230;232	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1267	1269	ACC	238;240;241	A,C;C;C	223,1;230;232	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1768	1770	ACC	223;226;230	A,G;C;C	208,1;221;222	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1822	1824	GCG	218;218;218	G;C;G	203;202;204	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1822	1824	GCG	218;218;218	G;C;G	203;202;204	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1945	1947	GGT	182;181;177	G;G;T	170;172;169	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1954	1956	AGC	169;166;163	A,G;G;C	157,1;157;151	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	182.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1972	1974	CCG	136;140;141	C,G;C,G;G,C	111,5;115,2;115,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6600	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3031	214.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1567	1569	CCG	216;219;219	C;C,T;G,T	206;211,1;206,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2564	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1847	137.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	192	C	183	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3414	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	220.5	0	.	p	.	0	E209K	NONSYN	625	627	GAA	841	843	AAA	258;262;273	A;A;A	252;253;264	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3414	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	220.5	0	.	p	.	0	A212E	NONSYN	634	636	GCA	850	852	GAA	274;273;275	G;A;A	266;261;271	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3414	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	220.5	1	SNP	p	G120K	1	.	.	358	360	AAG	574	576	AAG	269;266;269	A;A;G	253;255;252	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3414	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	220.5	1	SNP	p	A121N	1	.	.	361	363	AAC	577	579	AAC	270;270;270	A,T;A,G;C	255,1;257,1;255	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3414	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	220.5	1	SNP	p	N121D	0	.	.	361	363	AAC	577	579	AAC	270;270;270	A,T;A,G;C	255,1;257,1;255	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12038	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4812	247.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1328	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1021	128.1	1	SNP	p	V57M	1	.	.	169	171	ATG	502	504	ATG	255;259;256	A;T;G	245;247;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
